Singapore Paincare Holdings Limited reports a net loss for the financial year ended 30 June 2025 (FY2025). This financial reversal was driven by a confluence of factors, including operational difficulties, non-operating losses, and strategic investments. Management noted that the tightening of claims processes by insurers also impacted revenue.
• The financial outcome was negatively affected by necessary impairment charges, specifically those relating to goodwill and plant and equipment, due to the underperformance of various clinics
• The Group recorded a share of losses from a joint venture and associates, with the joint venture loss primarily caused by a revaluation loss on an investment
• In response to evolving market conditions, the Group undertook a significant rebranding exercise and increased investments in marketing and digital transformation initiatives, including the acquisition of AI technologies
